메뉴 건너뛰기




Volumn 5, Issue SUPPL.1, 2012, Pages

Molecular targets for therapy in systemic sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 5 AZA 2' DEOXYCYTIDINE; AZATHIOPRINE; BLEOMYCIN; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DASATINIB; DEXAMETHASONE; FASUDIL; FLUOROURACIL; IMATINIB; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NILOTINIB; PENICILLAMINE; PLACEBO; PREDNISONE; SEROTONIN; TERGURIDE; THYMOCYTE ANTIBODY; TOCILIZUMAB; VORINOSTAT;

EID: 84881017034     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-S1-S19     Document Type: Article
Times cited : (17)

References (23)
  • 4
  • 6
    • 0028920576 scopus 로고
    • Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic sclerosis
    • 10.1002/art.1780380309, 7880189
    • White B, Bauer EA, Goldsmith LA. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic sclerosis. Arthritis Rheum 1995, 38:351-360. 10.1002/art.1780380309, 7880189.
    • (1995) Arthritis Rheum , vol.38 , pp. 351-360
    • White, B.1    Bauer, E.A.2    Goldsmith, L.A.3
  • 7
    • 0031684342 scopus 로고    scopus 로고
    • Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis
    • 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O, 9751093
    • Steen VD, Medsger TA. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998, 41:1613-1619. 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O, 9751093.
    • (1998) Arthritis Rheum , vol.41 , pp. 1613-1619
    • Steen, V.D.1    Medsger, T.A.2
  • 8
    • 0033771114 scopus 로고    scopus 로고
    • Long-term outcomes of scleroderma renal crisis
    • Steen VD, Medsger TA. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 2000, 133:600-603.
    • (2000) Ann Intern Med , vol.133 , pp. 600-603
    • Steen, V.D.1    Medsger, T.A.2
  • 12
    • 35348967491 scopus 로고    scopus 로고
    • Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
    • 10.1186/ar2187, 2072889, 17767741
    • Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007, 9(Suppl 2):S3. 10.1186/ar2187, 2072889, 17767741.
    • (2007) Arthritis Res Ther , vol.9 , Issue.SUPPL. 2
    • Koch, A.E.1    Distler, O.2
  • 13
    • 0018386836 scopus 로고
    • Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma
    • Stachów A, Jabłońska S, Skiendzielewska A. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma. Acta Derm Venereol 1979, 59:1-5.
    • (1979) Acta Derm Venereol , vol.59 , pp. 1-5
    • Stachów, A.1    Jabłońska, S.2    Skiendzielewska, A.3
  • 14
    • 0023886092 scopus 로고
    • Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
    • 10.1016/0167-5273(88)90238-0, 3397197
    • Biondi ML, Marasini B, Bianchi E, and Agostoni A. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol 1988, 19:335-339. 10.1016/0167-5273(88)90238-0, 3397197.
    • (1988) Int J Cardiol , vol.19 , pp. 335-339
    • Biondi, M.L.1    Marasini, B.2    Bianchi, E.3    Agostoni, A.4
  • 16
    • 33847348491 scopus 로고    scopus 로고
    • Systemic sclerosis: a prototypic multisystem fibrotic disorder
    • 10.1172/JCI31139, 1804347, 17332883
    • Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567. 10.1172/JCI31139, 1804347, 17332883.
    • (2007) J Clin Invest , vol.117 , pp. 557-567
    • Varga, J.1    Abraham, D.2
  • 18
    • 0029064303 scopus 로고
    • The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
    • 10.1111/j.1476-5381.1995.tb14977.x, 1908489, 7582481
    • Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 1995, 115:622-628. 10.1111/j.1476-5381.1995.tb14977.x, 1908489, 7582481.
    • (1995) Br J Pharmacol , vol.115 , pp. 622-628
    • Bonhaus, D.W.1    Bach, C.2    DeSouza, A.3    Salazar, F.H.4    Matsuoka, B.D.5    Zuppan, P.6    Chan, H.W.7    Eglen, R.M.8
  • 19
    • 0034068805 scopus 로고    scopus 로고
    • Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B)receptors
    • 10.1038/sj.bjp.0703341, 1572101, 10821800
    • Glusa E, Pertz HH. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B)receptors. Br J Pharmacol 2000, 130:692-698. 10.1038/sj.bjp.0703341, 1572101, 10821800.
    • (2000) Br J Pharmacol , vol.130 , pp. 692-698
    • Glusa, E.1    Pertz, H.H.2
  • 20
    • 18144416218 scopus 로고    scopus 로고
    • Agonism at 5-HT2B receptors is not a class effect of the ergolines
    • 10.1016/j.ejphar.2005.03.010, 15862804
    • Jähnichen S, Horowski R, Pertz HH. Agonism at 5-HT2B receptors is not a class effect of the ergolines. Eur J Pharmacol 2005, 513:225-228. 10.1016/j.ejphar.2005.03.010, 15862804.
    • (2005) Eur J Pharmacol , vol.513 , pp. 225-228
    • Jähnichen, S.1    Horowski, R.2    Pertz, H.H.3
  • 21
    • 77957668307 scopus 로고    scopus 로고
    • Animal models of systemic sclerosis: prospects and limitations
    • 10.1002/art.27647, 20617524
    • Beyer C, Schett G, Distler O, Distler JH. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 2010, 62:2831-2844. 10.1002/art.27647, 20617524.
    • (2010) Arthritis Rheum , vol.62 , pp. 2831-2844
    • Beyer, C.1    Schett, G.2    Distler, O.3    Distler, J.H.4
  • 22
    • 69949186412 scopus 로고    scopus 로고
    • Criteria to select molecular targets for anti-fibrotic therapy
    • v12-3
    • Distler JH, Distler O. Criteria to select molecular targets for anti-fibrotic therapy. Rheumatology 2008, 47(Suppl 5):v12-3.
    • (2008) Rheumatology , vol.47 , Issue.SUPPL. 5
    • Distler, J.H.1    Distler, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.